$79.6B
$557,000
0.01% of portfolio
2,199
Q1 2024
Reduced 0.14%
$2.01B
$654,000
0.01% of portfolio
14,700
Q4 2021
Reduced 21.39%
$17.9B
$596,000
0.01% of portfolio
10,900
Q3 2024
Reduced 88.92%
$72.1B
$599,000
0.01% of portfolio
842
Q4 2024
New
$553M
$660,000
0.01% of portfolio
28,490
Q2 2021
Added 7.15%
$0
$284,000
0.01% of portfolio
12,994
Q3 2024
New
$14.7B
$404,000
0.01% of portfolio
6,579
Q1 2024
Reduced 1.35%
$8.14B
$428,000
0.01% of portfolio
2,369
Q4 2024
Reduced 36.57%
$7.03B
$652,000
0.01% of portfolio
13,430
Q4 2024
Reduced 37.05%
$202B
$654,000
0.01% of portfolio
5,437
Q3 2024
Added 7.75%
$696M
$641,000
0.01% of portfolio
23,000
Q1 2024
Added 17.95%
$113B
$252,000
0.01% of portfolio
914
Q4 2024
Added 14.25%
$144B
$333,000
0.01% of portfolio
786
Q4 2024
Reduced 0.13%
$0
$360,000
0.01% of portfolio
4,044
Q2 2024
New
$0
$401,000
0.01% of portfolio
9,621
Q2 2024
New
$4.39B
$293,000
0.01% of portfolio
6,400
Q4 2024
New
$13.9B
$486,000
0.01% of portfolio
2,125
Q4 2024
New
$290B
$416,000
0.01% of portfolio
1,888
Q4 2024
Reduced 21.46%
$25.6B
$366,000
0.01% of portfolio
3,500
Q3 2023
Reduced 0.14%
$18.8B
$285,000
0.01% of portfolio
1,225
Q4 2024
New
$105B
$550,000
0.01% of portfolio
3,110
Q4 2024
Added 0.71%
$0
$365,000
0.01% of portfolio
4,641
Q2 2024
New
$234M
$40,000
0.0% of portfolio
84,800
Q4 2024
Reduced 11.3%
$0
$0
0.0% of portfolio
464,932
Q4 2024
Reduced 14.85%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.85%
-
$0
0.0% of portfolio
-
Q1 2024
New
$67.9B
$227,000
0.0% of portfolio
2,202
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2023
New
$79.5B
$135,000
0.0% of portfolio
1,079
Q4 2024
New
Primo Brands Corp Calss A
-
$0
0.0% of portfolio
-
Q4 2024
New
Stride Inc (Lrn) 18.9109 Con
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 10.0%
Royal Caribbean Cruises (Rcl)
-
$0
0.0% of portfolio
-
Q3 2023
New
Ptc Therapeutics Inc (Ptct)
-
$0
0.0% of portfolio
-
Q2 2022
New
Patrick Industries Inc (Patk)
-
$0
0.0% of portfolio
-
Q4 2022
New
Mirum Pharmaceuticals (Mirm)
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 12.5%
Lumentum Holdings (Lite) 10.
-
$0
0.0% of portfolio
-
Q4 2022
Reduced 40.0%
Live Nation (Lyv) 9.4469 Conv
-
$0
0.0% of portfolio
-
Q4 2022
New
Exact Sciences (Exas) 8.2076
-
$0
0.0% of portfolio
-
Q2 2020
Reduced 25.0%
Biomarin Pharmaceutical (Bmrn)
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 85.71%
Array Technologies Inc (Arry)
-
$0
0.0% of portfolio
-
Q1 2024
Added 100.0%
Apellis Pharmaceuticals Inc (A
-
$0
0.0% of portfolio
-
Q3 2020
New
Pg&E Corp 6, Due 12/1/27 Cv
-
$0
0.0% of portfolio
-
Q4 2024
New
Boeing A 6 10/15/27 (5.828 Cr
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.88%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.02%
$746M
$87,000
0.0% of portfolio
23,500
Q1 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.82%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 2.38%